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Abstract
Background: In the United Kingdom (UK), the National Treatment Agency for Substance Misuse
(NTA) considers retention to be the best available measure of drug treatment effectiveness.
Accordingly, the NTA has set local treatment systems the annual target of retaining 75% of clients
for 12 weeks or more, yet little assessment of this target or factors that improve retention has
occurred. This study aims to quantify the proportion of people retained in treatment for 12 weeks
in the North West of England and to identify factors associated with premature drop out.
Methods: The North West National Drug Treatment Monitoring System (NDTMS) was used to
identify treatment durations for everyone beginning a treatment episode between 1st April 2005
and 31st March 2006 (N = 16626). Odds ratios, chi-square and logistic regression analyses
compared clients retained for 12 weeks to clients whose discharge record showed they had
prematurely dropped out before 12 weeks. Individuals with other outcomes were excluded from
analyses.
Results: 75% of clients (N = 12230) were retained for 12 weeks and 10% (N = 1649) dropped out
prematurely. Multivariate analysis showed drop out was more likely among Asian drug users
(adjusted odds ratio 1.52, 95% CI 1.12 to 2.08) than their white equivalents. Drop out was more
likely among residents of Cumbria and Lancashire (adjusted odds ratio 1.80, 95% CI 1.51 to 2.15)
and Greater Manchester (adjusted odds ratio 2.00, 95% CI 1.74 to 2.29) than Cheshire and
Merseyside and less likely among alcohol users (adjusted odds ratio 0.73, 95% CI 0.59 to 0.91). A
significant interaction between age and deprivation was observed. For those aged 18 to 24 years
and 25 to 34 years, drop out was significantly more likely among those living in affluent areas. For
those in the older age groups the converse effect was observed.
Conclusion: In combination, the drug treatment systems of the North West achieved the
Government's retention target in 2005/06. A number of factors associated with drop out were
identified; these should be considered in strategies that aim to improve retention. Drop out and
retention are measures that capture the joint effect of many factors. Further work is required to
evaluate the effect of deprivation.
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Background
According to the World Health Organization, there are an
estimated two billion alcohol users, 1.3 billion smokers
and 185 million users of illicit drugs in the world. In
2000, these substances contributed to 12.4% of deaths
worldwide [1]. While illicit drug use constitutes the small-
est proportion of psychoactive substance use, it is the cat-
egory often perceived as most harmful, and consequently,
significant resources are employed globally to prevent and
reduce the use of illicit substances. In the United Kingdom
(UK), the drugs considered to have the greatest negative
consequences are opiates (predominantly heroin) and
stimulants (predominantly cocaine and crack cocaine)
and it is a reduction in the use of these problematic drugs
which continues to be the major focus of the national
drug strategy [2].
In many countries, including the UK, effective treatment is
understood to play a central role in enabling individuals
to adopt drug free lives [2,3]. In recognition of the impor-
tance of treatment, the amount allocated by the Depart-
ment of Health to local partnerships to support drug
treatment has swelled to £385 million in 2006/07 [4]. In
combination with other measures including an expanded
workforce, reduced waiting times and the development of
a criminal justice programme designed to divert drug
users from crime into treatment, this additional funding
saw 195,464 people accessing structured drug treatment
between 1st April 2006 and 31st March 2007, compared to
85,000 in 1998 when the national drug strategy was
launched [5], a rise of 130%. Increasing treatment uptake
is, however, only one measure of success. Unplanned dis-
charge, or 'drop out', is a well-recognised phenomenon of
drug treatment, with people dropping out before partici-
pating fully in elements of treatment that will engender
change [6].
In the United States of America (USA), longer durations of
drug treatment are reported to be a consistent predictor of
favourable treatment outcomes [7-10] and retaining drug
users in treatment should be an important intermediate
goal of the treatment system. In the UK, findings from the
National Treatment Outcome Research Study, the only
major UK-based, prospective cohort treatment outcomes
study reported that clients who stayed in residential treat-
ment programmes (programmes which typically see peo-
ple with more severe problems at intake than those
treated in the community) for 'critical times' had better
outcomes at one-year follow up than those who were not
retained [6]. Drawing on evidence from the USA and UK,
the National Treatment Agency for Substance Misuse
(NTA), the Government body overseeing the effectiveness
of the drug treatment system in the UK, decided that indi-
viduals not retained in treatment for at least three months
were unlikely to experience long-term benefits [11].
Accordingly, the NTA introduced a retention target in
treatment plans for the first time in 2004/05, with 75% of
individuals expected to be retained for 12 weeks or more
during each annual reporting cycle [12]. Treatment provi-
sion, overseen by drug partnerships called Drug (and
Alcohol) Action Teams (D [A]ATs), were clearly expected
to change their practices in order to achieve this retention
target but were obviously not expected to distort their
treatment data accordingly. This risk was monitored by
the NTA to expose any services and systems that manipu-
lated their delivery in order to appear to achieve this per-
formance indicator, in the absence of any real
improvement [11].
To date, there has been little independent assessment of
the impact of this government target on the number of
drug users actually retained in treatment for 12 weeks.
Furthermore, most of the existing evidence regarding fac-
tors associated with longer treatment episodes is derived
within the USA, with less information available about fac-
tors that influence treatment retention in other countries.
Factors associated with retention in the UK, where the
majority of treatment is delivered via the National Health
Service and charitable/voluntary organisations may be
very different from those influencing treatment retention
in the USA where patients pay for treatment and are dis-
charged for non-payment [13]. In the UK, the factors that
influence treatment retention and attrition remain poorly
understood.
The North West of England (mid-year population of
6,846,249 in 2005) is a region containing both urban and
rural and both deprived and affluent areas. It is also a
region with a relatively high prevalence of problematic
drug use. While the exact number of drug users living in
the region remains unknown due to the covert nature of
the behaviour, estimates suggest that the level of problem-
atic drug use is as high as 52 per 1,000 of male population
aged 15 to 44 years in some metropolitan centres [14].
Between 1st April 2005 and 31st March 2006, 35503
North West residents were in contact with structured drug
treatment services and these individuals accounted for
almost 20% of the total number of people in contact with
treatment services in England [15]. The North West region
was therefore chosen as the setting for this study because
it represents an area with a high prevalence of problematic
drug use and treatment activity. The study set out to quan-
tify the proportion of individuals retained in treatment in
the North West of England for 12 weeks or more and to
investigate the factors associated with treatment drop out,
compared to retention, using established monitoring sys-
tems.BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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Methods
Data collection
The National Drug Treatment Monitoring System
(NDTMS) records details of individuals in contact with
structured drug treatment services in England. Such serv-
ices include substitute prescribing, structured psychoso-
cial interventions and abstinence-based services but
exclude agencies such as needle exchange services [16]. It
is mandatory for staff working in these services to report
to their regional NDTMS key items of data relating to all
drug users who present to their service for treatment. Data
are collected and checked monthly and are reported on an
annual basis (1st April to 31st March). To maintain client
anonymity, data are collected in a pseudo-anonymous
form with an individual identified by their 'attributor
code' comprised of their initials, date of birth, sex and
their D(A)AT of residence.
The NDTMS database for the North West of England
(includes the Cheshire and Merseyside, Cumbria and Lan-
cashire and Greater Manchester geographies) was interro-
gated to retrospectively identify all individuals who had a
triage date, and thus began a new episode of treatment,
within the 2005/06 reporting period. Measures of treat-
ment retention were established in accordance with NTA
guidance [12]. Firstly, all clients under the age of 18 were
removed from the dataset because the majority of young
people participate in short-term interventions not
designed to last for 12 weeks. The triage and discharge
dates were used to determine the length of each treatment
episode. Where two episodes for the same person over-
lapped (the treatment start date of the second episode
being before the discharge date of the first episode), the
individual was recorded as being continuous in the treat-
ment system and the triage date of the first episode and
discharge date of the second was used to identify the
length of contact. An individual was also considered to be
in continuous treatment if the start date of a second epi-
sode of treatment was within three weeks of the discharge
date of the first episode of treatment, even if they dropped
out prematurely from the first agency (three weeks reflects
the effectiveness target that an individual should be seen
within three weeks of being referred to a service [12]). An
individual is defined as being retained in treatment if their
total treatment episode within the system was 12 weeks or
longer. An individual was deemed to have dropped out
prematurely if their total treatment episode lasted for less
than 12 weeks and the reason for discharge was coded as
'dropped out/left'. Individuals who were not in the treat-
ment system for 12 weeks who had other discharge rea-
sons (such as 'died', 'sent to prison') were excluded from
the analyses. To avoid correlations in the data and adhere
to the NTA's methodology for retention analysis, attribu-
tor codes were used to remove double counting of indi-
viduals within the dataset. Drop out or retention status
was defined using an individuals' most recent treatment
episode.
Other variables obtained from the NDTMS database were
sex, age at triage assessment, ethnicity code, D(A)AT of
residence, route of referral into treatment and up to three
drugs. D(A)AT of residence was recoded to public health
zone, and route of referral was recoded into criminal jus-
tice or otherwise. North West NDTMS data for 2003/04
and 2004/05 were used to identify whether each individ-
ual had been in contact with treatment within these two
periods (used to define 'recent contact'). The variables
included in the final dataset are detailed in Table 1. Dep-
rivation was assessed using a population weighted Index
of Multiple Deprivation (IMD) that was available for each
D(A)AT from the North West Public Health Observatory.
The IMD (2004) combines indicators collected from rou-
tine data relating to the following seven domains: income,
employment, health and disability, education, skills and
training, barriers to housing and services, living environ-
ment and crime [17]. A higher IMD score indicates a
greater level of deprivation. Based upon their IMD scores,
D(A)ATs were separated into deprivation quintiles (five
D[A]ATs were allocated to quintiles one and five, and four
each to quintiles two, three and four; Table 2). Each indi-
vidual was assigned a deprivation score based upon their
D(A)AT of residence. Data manipulation and matching
was undertaken using Microsoft Access.
Data analysis
All variables were investigated for erroneous or missing
values. Bivariate analyses were conducted on all data.
Only records with complete data were included in multi-
variate analyses to ensure that Likelihood Ratio Tests
(LRT) compared nested models. For the purpose of this
analysis, the quantitative variable 'age at triage' was cate-
gorised as follows: 18–24, 25–34, 35–44, 45–54 and 55–
74.
Bivariate analyses between outcome (retention or drop
out) and all explanatory variables were assessed inde-
pendently using odds ratios and chi-square analyses. For-
ward stepwise logistic regression was then used to identify
factors associated with drop out following simultaneous
adjustment for other variables. Variables whose signifi-
cance in the bivariate analyses was P ≤ 1.0 were entered
into the model and their effects tested separately. Varia-
bles were entered into the model in the following order:
age, ethnicity, opiate user, alcohol user, recent treatment
contact, public health zone and deprivation. Interactions
between age and all other explanatory variables were
tested because previous research in the UK showed drug
treatment outcomes varied significantly with age [18].BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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The LRT was used for three analyses. 1) to test the null
hypothesis that the variable under consideration was not
significantly associated with drop out; 2) to compare a
model with a linear trend with a model with individual
effects across strata for ordinal explanatory variables (age
group and deprivation quintile) and 3) to compare a
model with and without an interaction term between age
group and, separately, each other variable. A LRT statistic
of P < 0.05 indicated significant differences between the
two models being compared. For model simplicity, com-
mon odds ratios were used where a linear trend was iden-
tified and interaction terms were not included in the
model if the interaction term did not significantly
improve the model's fit. Additive models were not consid-
ered because odds were being modelled. Pearson's chi-
square was used to evaluate the fit of the model to the
data. All analyses were undertaken using STATA inter-
cooled version 8 [19].
The Ethics Committee of the London School of Hygiene
and Tropical Medicine granted ethical approval.
Results
In 2005/06, 22330 triage assessments were recorded by
the NDTMS database for the North West of England for
drug users aged between 18 and 74. This figure included
multiple triage assessments for the same individual when
they had been seen by two different treatment services or
had started a new period of treatment at the same service
on multiple occasions. Following data preparation in the
manner detailed above, 16626 individuals aged between
18 and 74 began a new episode of treatment in the North
West of England in 2005/06. Data on treatment outcomes
were unavailable for 272 (1.6%) individuals. Of the
remaining 16354 people, 12230 (74.8%) were retained in
treatment for 12 weeks or more and 1649 (10.1%)
dropped out of treatment before 12 weeks. A further 2475
(15.1%) episodes resulted in other treatment outcomes.
These other treatment episode outcomes were as follows:
treatment completed in less than 12 weeks, client drug
free (n = 275, 1.7%), treatment completed in less than 12
weeks, client not drug free (n = 326, 2.0%), treatment
withdrawn, contract breached by client (n = 379, 2.3%),
no appropriate treatment available (n = 106, 0.6%), treat-
ment declined by client (n = 1, <0.1%), inappropriate
Table 1: Description of the variables included in the final dataset
Variable Description
Attributor code (initials, date of birth, sex 
and D[A]AT of residence)
Used to identify an individual
Sex Female or male
Age at triage Categorised into 18–24, 25–34, 35–44, 45–54 and 55–74
Date of triage and discharge Used to identify the start and end of each episode of treatment
Outcome code Retained, dropped out or other (see results section for other outcomes)
Ethnicity code White (white British, white Irish, white other)
Mixed (white and black Caribbean, white and black African, white and Asian, other mixed)
Asian/Asian British (Indian, Pakistani, Bangladeshi, other Asian)
Black/Black British (Caribbean, African, other black)
Other (Chinese, other)
D(A)AT of residence Recoded to public health zone of residence
Cheshire and Merseyside (Cheshire, Halton, Knowsley, Liverpool, Sefton, St Helens, Warrington, 
Wirral)
Cumbria and Lancashire (Blackburn, Blackpool, Cumbria, Lancashire)
Greater Manchester (Bolton, Bury, Manchester, Oldham, Rochdale, Salford, Stockport, Tameside, 
Trafford, Wigan)
Referral source Recoded to criminal justice and non-criminal justice referral route
Non-criminal justice referral route (Accident and Emergency departments, Community Care 
Assessment, Connexions, drug service: non-statutory, drug service: statutory, Education Services, 
Employment Services, General Practitioner, looked after children, Psychiatry, self, Social Services, 
needle exchange services)
Criminal justice referral route (Arrest Referral/Drug Interventions Programme, CARAT, Drug 
Treatment and Testing Order, Probation, Youth Offending Team)
Recent treatment contact No (no treatment contact in 2003/04 or 2004/05) or yes (treatment contact in 2003/04 or 2004/05)
Opiate use No or yes (heroin, methadone, other opiates)
Stimulant use No or yes (amphetamine, cocaine, crack cocaine)
Alcohol use No or yes
Deprivation Assessed using a composite score: the Index of Multiple Deprivation. The index is based on data for 
seven domains: income, employment, health and disability, education, skills and training, barriers to 
housing and services, living environment and crime. A higher score reflects a higher level of deprivation. 
Table 2 shows the scores for each D(A)AT area and the quintiles used for the analyses.BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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referral (n = 26, 0.2%), client referred on (n = 555, 3.4%),
client moved away from area (n = 103, 0.6%), client went
to prison (n = 308, 1.9%), client died (n = 23, 0.1%),
other outcome (n = 220, 1.3%), outcome not known (n =
153, 0.9%).
The characteristics of those dropping out of treatment and
those retained are displayed in Table 3. Bivariate analyses
showed that drop out was significantly associated with
seven variables (Table 4). Firstly, those who had recently
been in contact with treatment were less likely to drop out
than those who had not (odds ratio 0.84, 95% confidence
interval 0.76 to 0.93). Secondly, the odds of drop out were
significantly higher among residents of Cumbria and Lan-
cashire (odds ratio 1.65, 95% confidence interval 1.43 to
1.90) and Greater Manchester (odds ratio 1.90, 95% con-
fidence interval 1.68 to 2.16) than residents of Cheshire
and Merseyside. For those people who were resident in
areas categorised as being in deprivation quintiles two to
five, the odds of drop out were significantly greater than
the odds of drop out for those living in the most deprived
areas (quintile one). The relationship between age and
treatment outcome showed an inverse linear trend, with
the odds of drop out decreasing with increasing age. With
respect to the drug profile, the odds of drop out was sig-
nificantly lower for individuals who were opiate users
(odds ratio 0.79, 95% confidence interval 0.71 to 0.88),
and for alcohol users (odds ratio 0.74, 95% confidence
interval 0.59 to 0.91). The use of alcohol was recorded for
435 (4.4%) opiate users and 574 (9.8%) stimulant users.
Only 150 individuals were recorded as using all three cat-
egories of drugs, while 1654 were reported as not using
any of these drugs (and were users of cannabis or benzo-
diazepines for example). Finally, the odds of drop out var-
ied according to ethnicity, with Asian drug users more
likely to drop out than their white counterparts (odds
ratio 1.97, 95% confidence interval 1.45 to 2.67). Other
variables were not significantly associated with treatment
outcome.
Logistic regression analysis (Table 5) showed that drop
out continued to be significantly more likely among Asian
drug users compared to white drug users in multivariate
analyses (adjusted odds ratio 1.52, 95% confidence inter-
val 1.12 to 2.08). Drop out was more likely among those
living in Cumbria and Lancashire (adjusted odds ratio
1.80, 95% confidence interval 1.51 to 2.15) and Greater
Manchester (adjusted odds ratio 2.00, 95% confidence
interval 1.74 to 2.29) than residents of Cheshire and Mer-
seyside and among people living in the least deprived
areas (adjusted odds ratio 2.92, 95% confidence interval
1.74 to 4.90). Drop out was significantly less likely among
alcohol users (adjusted odds ratio 0.73, 95% confidence
interval 0.59 to 0.91,). Age group was not significantly
associated with drop out once deprivation quintile was
included in the model.
Table 2: Deprivation quintile of Drug (and Alcohol) Action Teams
Drug (and Alcohol) Action Team Index of Multiple Deprivation score1 Deprivation quintile 
(1 = most deprived, 5 = least deprived)
Liverpool 49.82 1
Manchester 48.95 1
Knowsley 46.58 1
Salford 38.19 1
Halton 34.29 1
Blackpool 33.91 2
Rochdale 33.71 2
Blackburn 32.29 2
St Helens 31.95 2
Oldham 30.73 3
Wirral 30.06 3
Tameside 29.81 3
Bolton 29.41 3
Wigan 29.27 4
Sefton 26.12 4
Bury 23.53 4
Lancashire 21.80 4
Cumbria 21.57 5
Trafford 20.14 5
Warrington 19.33 5
Stockport 18.06 5
Cheshire 15.06 5
1 Source: North West Public Health Observatory, Centre for Public Health, Liverpool John Moores UniversityBMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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There was a significant interaction between age group and
deprivation and the coefficients from the logistic regres-
sion model were used to explore this further. Figure 1
shows that, for those aged 18 to 24 years, the odds of drop
out for deprivation quintile five (least deprived) were 1.93
(95% confidence interval 1.41 to 2.64) the odds of drop
out for deprivation quintile one (most deprived). A simi-
lar, though smaller, effect was evident for the 25 to 34 age
Table 3: Characteristics of those dropping out of, and retained in, drug treatment (N = 13879)
Explanatory variables Retained (controls) – n (%) Drop out (cases) – n (%)
SITUATIONAL/ORGANISATIONAL FACTORS
Recent treatment contact
No 5476 (44.8%) 809 (49.1%)
Yes 6754 (55.2%) 840 (50.9%)
Referral route1
Non-criminal justice 7801 (73.2%) 1084 (74.6%)
Criminal justice 2854 (26.8%) 370 (25.4%)
Area of residence (public health zone)
Cheshire and Merseyside 4702 (38.4%) 424 (25.7%)
Cumbria and Lancashire 2942 (24.1%) 438 (26.6%)
Greater Manchester 4586 (37.5%) 787 (47.7%)
Deprivation
1 (most) 3465 (28.3%) 364 (22.1%)
2 1800 (14.7%) 286 (17.3%)
3 2268 (18.5%) 328 (19.9%)
4 2979 (24.4%) 388 (23.5%)
5 (least) 1718 (14.0%) 283 (17.2%)
PERSONAL CHARACTERISTICS
Sex
Female 3359 (27.5%) 438 (26.6%)
Male 8871 (72.5%) 1211 (73.4%)
Age group (years)
18–24 1902 (15.6%) 362 (22.0%)
25–34 5487 (44.9%) 780 (47.3%)
35–44 4071 (33.3%) 436 (26.4%)
45–54 654 (5.3%) 64 (3.9%)
55–74 116 (0.9%) 7 (0.4%)
Ethnicity2
White 11343 (95.3%) 1462 (93.5%)
Mixed 142 (1.2%) 23 (1.5%)
Asian/Asian British 209 (1.8%) 53 (3.4%)
Black/Black British 130 (1.1%) 19 (1.2%)
Other 76 (0.6%) 7 (0.4%)
DRUG USE
Opiate user
No 3530 (28.9%) 560 (34.0%)
Yes 8700 (71.1%) 1089 (66.0%)
Stimulant user
No 7087 (57.9%) 961 (58.3%)
Yes 5143 (42.1%) 688 (41.7%)
Alcohol user
No 11254 (92.0%) 1550 (94.0%)
Yes 976 (8.0%) 99 (6.0%)
1 N = 12109; for 354 individuals the data were missing and for a further 1416 'other' was recorded so it was not possible to identify whether or not 
the referring agency was a criminal justice service.
2 N = 13464BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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group. Conversely, for those aged 55 to 74 years, the odds
of drop out for deprivation quintile five were 0.37 (95%
confidence interval 0.18 to 0.73) the odds of drop out for
those living in deprivation quintile one. A similar effect of
smaller magnitude was observed for the 45 to 54 year age
group. No interactions between age group and other
explanatory variables were observed. Other explanatory
variables (opiate use and recent treatment contact) were
not significantly associated with treatment outcome fol-
lowing simultaneous adjustments for other variables. The
goodness of fit test suggested that the final model was not
a good fit to the data (Pearson's χ2 = 322.16, P = 0.009).
Discussion
Retention in drug treatment is considered by the NTA to
be the best available measure of treatment effectiveness
[4]. To encourage a reduction in drop out rates, treatment
retention measures were included in local partnership
treatment plans and Primary Care Trust local delivery
plans for the first time in 2004/05 [12], with 75% of drug
users expected to be retained in treatment for at least 12
weeks during each annual reporting period [4]. Rates of
retention can be improved by better understanding factors
associated with premature drop out. The aims of the
present study were to assess whether the retention target
was achieved in the North West of England in 2005/06
Table 5: Factors affecting drop out from drug treatment, 
multivariate analysis (N = 13464)
Explanatory variables Adjusted odds ratio (95% 
confidence interval)
Ethnicity
White Reference
Mixed 1.14 (0.73 – 1.79)
Asian/Asian British 1.52** (1.12 – 2.08)
Black/Black British 1.10 (0.67 – 1.79)
Other 0.69 (0.32 – 1.51)
Alcohol user
No Reference
Yes 0.73** (0.59 – 0.91)
Area of residence (public health 
zone)
Cheshire and Merseyside Reference
Cumbria and Lancashire 1.80*** (1.51 – 2.15)
Greater Manchester 2.00*** (1.74 – 2.29)
Deprivation
1 (most) Reference
2 1.41 (0.85 – 2.34)
3 1.05 (0.65 – 1.70)
4 1.06 (0.67 – 1.70)
5 (least) 2.92*** (1.74 – 4.90)
Age group (years)1 0.88 (0.76 – 1.01)
Effect of interaction between age 
group and deprivation
1 (most) Reference
2 0.92 (0.75 – 1.14)
3 1.01 (0.83 – 1.24)
4 0.95 (0.78 – 1.15)
5 (least) 0.66*** (0.52 – 0.83)
Other variables entered into the model: opiate use, recent treatment 
contact.
1 The effect of age group showed a linear trend; the adjusted odds 
ratio represents the common odds ratio across strata.
** P ≤ 0.01, *** P ≤ 0.001
Goodness of fit: Pearson's χ2 = 322.16, P = 0.009
Table 4: Factors affecting drop out from drug treatment, 
bivariate analyses (N = 13879)
Explanatory variables Mantel-Haenszel odds ratio 
(95% confidence interval)
Recent treatment contact
No Reference
Yes 0.84*** (0.76 – 0.93)
Referral route1
Non-criminal justice Reference
Criminal justice 0.93 (0.82 – 1.06)
Area of residence (public health 
zone)
Cheshire and Merseyside Reference
Cumbria and Lancashire 1.65*** (1.43 – 1.90)
Greater Manchester 1.90*** (1.68 – 2.16)
Deprivation
1 (most) Reference
2 1.51*** (1.28 – 1.78)
3 1.38*** (1.17 – 1.61)
4 1.24** (1.07 – 1.44)
5 (least) 1.57*** (1.33 – 1.85)
Sex
Female Reference
Male 1.05 (0.93 – 1.18)
Age group (years)
18–24 Reference
25–34 0.75*** (0.65 – 0.85)
35–44 0.56*** (0.48 – 0.65)
45–54 0.51*** (0.39 – 0.68)
55–74 0.32** (0.15 – 0.69)
Ethnicity2
White Reference
Mixed 1.26 (0.81 – 1.96)
Asian/Asian British 1.97*** (1.45 – 2.67)
Black/Black British 1.13 (0.70 – 1.84)
Other 0.71 (0.33 – 1.55)
Opiate user
No Reference
Yes 0.79*** (0.71 – 0.88)
Stimulant user
No Reference
Yes 0.99 (0.89 – 1.09)
Alcohol user
No Reference
Yes 0.74** (0.59 – 0.91)
1 N = 12109 individuals; for 354 individuals the data were missing and 
for a further 1416 'other' was recorded so it was not possible to 
identify whether or not the referring agency was a criminal justice 
service.
2 N = 13464
** P ≤ 0.01, *** P ≤ 0.001BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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and to identify factors associated with drop out. While a
number of factors associated with drop out are identified,
results also highlight the complexity of factors associated
with treatment outcomes.
Results show that, overall in the North West, the treat-
ment systems achieved the Government's retention target
in 2005/06, with 75% of people retained for 12 weeks or
more. Contextual information provides a more valuable
assessment of how services should be improved, and the
analyses presented here shows that current services are
failing to retain Asian drug users. Furthermore, demo-
graphic data from the 2001 census [20] shows that Asian
people are underrepresented in drug treatment services
while those from white, mixed, black and 'other' ethnici-
ties are adequately represented. While people of Asian
ethnicity account for 3.4% of the population of the North
West [20] they accounted for just 1.9% of the drug treat-
ment population (Table 3). This finding may reflect the
lower prevalence of drug use among Asian people
although a growing body of evidence indicates that drug
use exists among black and minority ethnic (BME) groups
and that it is increasing [21]. Qualitative research into the
extent and nature of drug use among young Asians sug-
gests that they were increasingly likely to use illicit drugs
and that knowledge and use of heroin, and perhaps crack
cocaine, indicated similar use to the general population of
the UK [22].
An alternative explanation is that Asian drug users are not
attracted by current treatment provision. A recent review
of literature on drug use and service provision for BME
communities in England reported a number of potential
reasons for differential treatment outcomes among drug
users from different ethnicities, over and above the possi-
bility of differing drug profiles [21]. Such reasons
included the ethnicity of drugs workers, communication
problems for those unable to speak English and a percep-
tion among drug users that drug workers lacked awareness
of their culture. No literature which evaluated outcomes
of culturally-sensitive initiatives in the clinical drug treat-
ment field in the UK could be identified by reviewers
although they pointed to two USA-based studies which
showed that culturally competent and culturally respon-
sive treatment was often associated with greater treatment
retention and longer treatment durations [23,24]. With
respect to drug use among young Asians, healthcare pro-
fessionals must be sensitive to the cultural context in
which their behaviours occur and in particular the poten-
tial conflict of being affiliated to two different and at times
incongruent cultural groups – British youth culture and
that of their ethnic origin [22]. Further work is required to
identify perceived barriers to treatment among Asian drug
users and the reasons why they are more likely to drop out
than their white counterparts, once contact has been initi-
ated.
With respect to other individual characteristics, studies in
the USA have reported longer durations of treatment for
older drug users [8,10,25] and for male drug users [10].
Evidence from a UK-based retrospective cohort study
showed no difference between men and women in rates
of drop out compared to drug free discharge but that
younger drug users (aged 10 to 19 years) were more likely
to drop out than their older counterparts [18]. Here, bivar-
iate analysis showed that the odds of drop out exhibited a
significant inverse linear relationship with age. However,
the multivariate analysis showed that age was not signifi-
cantly associated with drop out once adjusted for depriva-
tion and that a significant interaction between
deprivation and age existed. The effect of deprivation was
not included in the retrospective cohort study just detailed
so no assessment of the relationship between age and dep-
rivation is available.
A wealth of data exists which shows the relationship
between socio-economic status and health. In the North
West of England, standardised mortality rates by depriva-
tion show that the all-age rate for those in the most
deprived quintile of population is one and three quarter
times the rate for the most affluent quintile of the popula-
tion [26]. However, results presented here show a com-
plex relationship between deprivation and age and their
effects upon drug treatment outcomes (Figure 1). For
those aged between 18 and 24 years, people living in least
deprived areas were almost twice as likely to drop out of
treatment than those living in the most deprived areas. A
similar effect, of smaller magnitude, was observed for
those aged 25 to 34 years. For those in the oldest age
group, (55 to 74 years) the converse was true and those
living in the most deprived areas were less likely to drop
out than those living in the least deprived areas. A similar,
The association between deprivation and drop out from drug  treatment, by age Figure 1
The association between deprivation and drop out from drug 
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though smaller, effect was observed for those aged 45 to
55 years.
Encouraging treatment participation among younger drug
users is a well-recognised problem [14]. Younger drug
users are less likely to view their drug use as problematic
or view themselves as dependent upon drugs [27] and
young drug users living in affluent areas may be some-
what protected from the negative consequences of drug
use from their affluent families. It is not clear why older
drug users living in the most deprived environmental con-
ditions were the least likely to drop out and this finding
warrants further consideration. It should be noted how-
ever, that an ecological, rather than individual, measure of
deprivation was used and that affluent individuals live in
deprived areas and visa versa. It is conceivable that afflu-
ent areas have a lower prevalence of problematic drug use
and lower levels of service provision and that younger
drug users with less motivation to change are deterred
from using services to which they have to travel. Travelling
more than one mile to treatment has been shown in one
USA-based study to reduce the likelihood of a person
completing treatment by a half after the effects of demo-
graphic differences and the type of drugs used were con-
trolled [28] and the possible impact of travelling to
services requires further consideration in the UK.
Controlling for the effect of deprivation and other explan-
atory factors, significant differences in the odds of drop
out were observed for different areas of the North West of
England with the odds greater among residents of Cum-
bria and Lancashire and Greater Manchester than Chesh-
ire and Merseyside. Further work is needed to understand
what is different about these regions and what factors dif-
ferentially affect drop out. It is possible that there are dif-
ferences between these areas in the manner in which
treatment is delivered, or differences in client satisfaction
with the treatment process and it is important to consider
the potential influence of the quality of treatment on drop
out rates rather than simply emphasising the role of client
characteristics [10]. At the service rather than regional
level, previous UK-based work has already demonstrated
the effect the service can make on the number of clients
retained successfully in treatment for six months [29]. The
time people wait to access treatment will also influence
retention. Here, a person was deemed to be in continuous
treatment if they reappeared in treatment within three
weeks of leaving the first agency they were in contact with.
Individuals who dropped out of service and did not reap-
pear until more than three weeks had elapsed were
recorded as having dropped out so geographical areas
whose waiting times were longer than three weeks would
have a greater proportion of people reported as dropping
out. Unfortunately, no assessment of the impact of wait-
ing times on treatment outcomes can be made in this
study.
The only substance significantly associated with outcomes
was alcohol, with alcohol users less likely to drop out of
treatment than non-alcohol users. Following adjustment
for other variables, opiate use was found not be signifi-
cantly associated with treatment outcomes. The only
large-scale longitudinal, prospective cohort study of treat-
ment outcomes in the UK reported that there was no long-
term reduction in drinking among patients of drug treat-
ment programmes and authors concluded that poor
drinking outcomes required urgent attention [30]. That
alcohol use is considered as part of the overall drug profile
of people contacting drug treatment is therefore encourag-
ing, particularly in light of the role of alcohol in drug-
related deaths [31,32] and its exacerbation of chronic hep-
atitis C, currently the most significant infection affecting
drug users who inject in the UK [33]. It is possible, how-
ever, that this finding is a feature of reporting. The
NDTMS records up to three drugs for each person, with
those identified as most problematic (used most fre-
quently, associated with greatest health and criminal con-
sequences) reported preferentially. Alcohol is generally
perceived to be less problematic than illicit drugs and
individuals whose drug profile does not include alcohol
may represent drug users who use a larger range of illicit
drugs – those with the most severe drug problems. Alco-
hol use may therefore act as a proxy measure of less severe
drug problems. A recent investigation into the characteris-
tics of drug users in contact with structured drug treatment
reported that those whose drug profiles included alcohol
as a supplementary drug were younger, were less likely to
use heroin and were more likely to be referred into treat-
ment via the criminal justice system [34].
Previous research in the North West of England showed
that those referred from the criminal justice system were
significantly more likely to drop out and less likely to
complete treatment drug free than those referred from
non-criminal justice sources [18]. Here the route of refer-
ral was not significantly associated with treatment drop
out in the bivariate analysis. Most community sentences
last longer than 12 weeks; the now defunct Drug Treat-
ment and Testing Orders for example (orders that
required the offender to attend regularly both court and
treatment and provide a urine sample for drug testing)
became available nationally in October 2000 and could
last between six months and three years [35]. It is there-
fore conceivable that those referred from the criminal jus-
tice system were retained in treatment for 12 weeks due to
fear of breaking their order but had poorer long-term out-
comes because they lacked the intrinsic motivation for
behaviour change. However, the identification of poorer
outcomes for criminal justice referrals [18] relates to out-BMC Public Health 2008, 8:149 http://www.biomedcentral.com/1471-2458/8/149
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comes recorded between 1998 and 2001/02, while the
present study was undertaken after the introduction of
retention targets. If drug use is considered a chronic con-
dition defined by relapse and re-presentation [18,36], the
present finding that a high proportion of both criminal
justice and non-criminal justice referrals adhere to treat-
ment for at least 12 weeks reflects positively on current
policy and practice.
While this study investigated the effects of a variety of var-
iables, the goodness of fit test suggests that other impor-
tant covariates were missing from the model. This finding
hints at the complexity of factors associated with treat-
ment outcomes and confirms suggestions that drop out
and retention is an index that capture the impact of many
interrelated individual and process measures [7]. In par-
ticular, it was not possible to evaluate the effect of treat-
ment modality on treatment retention because an
individual's entire treatment episode could be comprised
of treatment within different modalities, yet treatment
modality is likely to have considerable bearing on treat-
ment outcomes. An examination of the covariate patterns
of the goodness of fit test showed discrepancies between
the observed and expected values for deprivation and fur-
ther work looking at the interaction between deprivation
and other explanatory variables is needed. However, the
reliability of the findings presented here is enhanced by
treatment outcome data being unavailable for only 272
(1.6%) individuals. Large-scale prospective cohort studies
of drug treatment outcomes are costly and time consum-
ing and the robustness of findings are often questionable
due to follow-up losses occurring differentially across
comparison groups. The use of well-established monitor-
ing systems provides a cost-effective means by which treat-
ment outcomes can be assessed [18] and while case
control studies are also prone to selection bias (with con-
trols not adequately reflecting the exposure history of
cases), here controls would have been cases if they had
dropped out of treatment before 12 weeks. Recall bias, an
accepted weakness of case control studies, did not affect
results of this study because data were collected prospec-
tively; exposure data recorded before treatment outcomes
were ascertained.
Problems associated with the use of routine data (for
example, inconsistencies in the manner in which informa-
tion is recorded) are somewhat mitigated in this study by
using nationally agreed definitions and reporting proto-
cols, standardised coding framework and data validation
checks [12]. Furthermore, the large sample size reduces
the impact of slight non-systematic variations, increases
the study power and reduces the likelihood of a Type II
error. However, the study relies totally on self-reported
data and the accuracy of such reports cannot be ascer-
tained. The standardisation of the drug treatment and
data reporting across England mean that the results from
the North West of England can be generalised to other
areas although results also show that the effect of factors
specific to each region would require further considera-
tion.
Conclusion
During the 2005/06 reporting period, 75% of clients were
retained in drug treatment in the North West of England.
Asian drug users were more likely to drop out of treatment
than their white equivalents, and further work into why
this is the case is needed in light of evidence to suggest the
drug profiles of Asian drug users are similar to those of
their white counterparts. Residents of Cumbria and Lanca-
shire and Greater Manchester were more likely to drop out
of treatment than people living in Cheshire and Mersey-
side, and work on the impact of treatment processes, treat-
ment quality and aspects of client satisfaction would be
welcomed. While overall, those living in the least
deprived areas were more likely to drop out than those liv-
ing in the most deprived areas, the effect of deprivation
varied significantly according to the age of the individual.
The effect of deprivation on treatment outcomes requires
further consideration, preferably using an individual,
rather than geographically aggregated measure of depriva-
tion. These findings show that personal characteristics,
process measures and situational factors all effect treat-
ment outcomes and highlight the complexity of factors
associated with treatment success. The large sample size,
small proportion of missing data and the inclusion of data
quality and standardisation measures increase the validity
and reliability of these findings. Finally, the NTA are cur-
rently revising the retention target, which is due to change
for the 2008/09 reporting cycle. To date, it is not clear how
the retention target will change, or whether 12 weeks will
continue to be the retention benchmark.
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